The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

The psoriatic arthritis treatment market is forecasted to achieve notable growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 10%, as per The Business Research Company’s market report!

Read More On The Psoriatic Arthritis Treatment Market Report 2022 – https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

The Psoriatic Arthritis Treatment Market Size In 2022 And Forecast

The global psoriatic arthritis treatment market is expected to grow from $7.89 billion in 2021 to $8.92 billion in 2022 at a compound annual growth rate (CAGR) of 13.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The psoriatic arthritis treatment market is expected to reach $13.17 billion in 2026 at a CAGR of 10.2%.

The psoriatic arthritis treatment market consists of the sale of psoriatic arthritis drugs used for the treatment of psoriatic arthritis by entities producing drugs for psoriatic arthritis.

Request for A Sample Of The Global Psoriatic Arthritis Treatment Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp

Rise In The Prevalence Of Psoriasis & Psoriatic Arthritis Disease Is Driving The Growth Of The Psoriatic Arthritis Treatment Market

According to the national psoriasis foundation, more than 8 million Americans have psoriasis. According to the National Psoriasis Foundation, in the USA, about 30% of people with psoriasis also develop psoriatic arthritis. Thus, an increase in the prevalence of psoriasis & psoriatic arthritis disease drives psoriatic arthritis treatment market growth.

Competitive Landscape And The Regional Analysis Of The Psoriatic Arthritis Treatment Market

Major players in the psoriatic arthritis treatment market are AbbVie, Amgen, Johnson & Johnson, Bristol-Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly And Company, Pfizer, UCB Biosciences Inc and Hoffmann La Roche Ltd.

The Psoriatic Arthritis Treatment Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the psoriatic arthritis treatment market.

Developing Of Novel Drugs – A Key Trend In The Psoriatic Arthritis Treatment Market

The development of novel drugs such as Janus kinase (JAK) inhibitors for treating psoriatic arthritis is shaping the market. Janus kinase (JAK) inhibitors are orally administered small molecules emerging as a novel treatment for psoriatic arthritis patients. There are three JAK inhibitors approved for the treatment of autoimmune diseases – tofacitinib, baricitinib, and upadacitinib. Among them, Xeljanz (tofacitinib) and Xeljanz (tofacitinib) XR are the first Janus kinase (JAK) inhibitors that have been approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). They are used to treat adult patients with active psoriatic arthritis (PsA), who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).

Psoriatic Arthritis Treatment Market Segmentation By The Business Research Company

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Biologics, Others

2) By Route of Administration: Oral, Parenteral, Topical

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Here Are Some Reports Related To The Psoriatic Arthritis Treatment Market –

Arthritis Monoclonal Antibodies Global Market Report 2022

Adalimumab, Infliximab And Etanercept Biosimilars Market 2022

Rituximab Biosimilars Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: